updates in the diagnosis, risk stratification & treatment of aml: who, icc, and eln classifications
Published 1 year ago • 437 plays • Length 2:31Download video MP4
Download video MP3
Similar videos
-
3:47
the impact of cytogenetic-risk stratification on aml outcomes
-
1:29
updates on the diagnosis, risk stratification and management of hl
-
1:33
updates to the icc classification of aml
-
2:03
aml risk stratification
-
3:13
validation of 2022 diagnostic & prognostic classifications of aml
-
4:34
the genetics of acute myeloid leukemia (aml)
-
32:50
webinar on who 5th edition updates - myeloid neoplasm& diagnostic approach to acute myeloid leukemia
-
3:16
identifying low- and high-risk aml
-
3:20
comparing the icc and who classifications for secondary aml and their impact on clinical practice
-
3:00
the classification of aml and the role of genetic biomarkers in the management of aml
-
2:45
continuity of care for patients with hematological predispositions to aml
-
3:55
updates in newly diagnosed and r/r aml
-
0:59
developing lsc-targeting agents in aml: progress and current therapeutic capacity
-
0:54
idh inhibitors and the evolving aml treatment paradigm
-
3:37
the future of aml treatment
-
3:47
update on the guidelines for the diagnosis, grading & management of icaht following car-t therapy
-
0:59
idh inhibitors in aml
-
1:02
the impact of sequencing in aml
-
1:40
updates on the use of molecular monitoring to detect mrd in aml
-
2:41
an overview of the latest advances in hematology
-
1:51
thrombotic and bleeding complications in al amyloidosis